our impact

Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit

Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit

First esophageal precancer detection event utilizing an EsoGuard mobile test unit to be hosted today by Florida Digestive Health Specialists in Sarasota, Florida.

Read More

Veris Health Joins CancerX Partnership as Founding Member

Veris Health announced its participation as a founding member of CancerX — a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society, alongside the Office for the National Coordinator for Health Information Technology and Office of the Assistant Secretary for Health.

Read More

Lucid Diagnostics Presents EsoGuard® and EsoCheck® Data at DDW 2023

Lucid Diagnostics Presents EsoGuard® and EsoCheck® Data at DDW 2023

EsoGuard® continues to demonstrate excellent esophageal precancer and cancer detection performance, including in most prevalent and challenging precancer subgroup—short segment non-dysplastic Barrett's Esophagus EsoCheck® cell collection performed with 98 percent technical success and high DNA yields in real-world study of 1483 patients.

Read More

Lishan Aklog Presents Veris Health at LSI USA'23 Emerging Medtech Summit

Lishan Aklog, MD presents Veris Health, a digital health company developing the first intelligent implantable vascular access port with biologic sensors and wireless communication to improve personalized cancer care through remote patient monitoring, at LSI USA'23 Emerging Medtech Summit.

Read More

First #CheckYourFoodTube precancer testing event

Lucid Diagnostics holds the first #CheckYourFoodTube precancer testing event in partnership with San Antonio Fire Department to test nearly 400 firefighters for esophageal precancer during Firefighter Cancer Awareness Month.

Read More

Detecting “Pre-cancer” Is the New Prevention with Dr. Lishan Aklog

Fran Drescher once said, "Stage 1 is the cure." Not any longer. Medical technology and genetics have come so far these days that it's now possible never to get cancer in the first place. At least some cancers that is.

Read More

press releases

Read the latest news from PAVmed.

February 16, 2024

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program

February 15, 2024

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony

February 8, 2024

Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors